Nasdaq Markets

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, gr

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Sea Ltd (Symbol: SE). The average 12-month price target for SE — averaging the work of 7 analysts — reveals an average price target of $74.28/share. That's a whop

In recent trading, shares of Imperial Oil Ltd (Symbol: IMO) have crossed above the average analyst 12-month target price of $17.53, changing hands for $18.51/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on va

In recent trading, shares of Cheniere Energy Partners L P (Symbol: CQP) have crossed above the average analyst 12-month target price of $38.44, changing hands for $39.28/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: dow

In recent trading, shares of UMB Financial Corp (Symbol: UMBF) have crossed above the average analyst 12-month target price of $58.00, changing hands for $60.85/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on

In recent trading, shares of United Bankshares Inc (Symbol: UBSI) have crossed above the average analyst 12-month target price of $30.67, changing hands for $32.05/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade

Looking at the universe of stocks we cover at Dividend Channel, on 6/10/20, Franco-Nevada Corp (Symbol: FNV) will trade ex-dividend, for its quarterly dividend of $0.26, payable on 6/25/20. As a percentage of FNV's recent stock price of $129.15, this dividend works out to app

In recent trading, shares of Trustmark Corp (Symbol: TRMK) have crossed above the average analyst 12-month target price of $26.33, changing hands for $26.95/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on val

(RTTNews) - Shares of Callon Petroleum Co. (CPE) are surging almost 48 percent or $0.66 in Monday's morning trade at $2.04 despite no stock-specific news. The stock has traded in a range of $0.38 to $7.01 in the past 52 weeks.

(RTTNews) - Shares of Enochian Biosciences Inc. (ENOB) surged nearly 140% on Monday morning. The clinical stage biotechnology company said it successfully completed a INTERACT meeting with the FDA for a potential cure for HIV.

Capital markets are constantly evolving and changing. Instrumental to this transformation are financial technology (fintech) companies who are playing a unique role in creating innovative solutions, services, and products that are reshaping the industry.

When it comes to saving for retirement, your 401(k) is one of the most powerful tools available. Many workers aren't taking full advantage and are missing out on valuable opportunities to save more.

(RTTNews) - FibroGen, Inc. (FGEN) announced the beginning of an open-label, randomized, parallel-arm study in Italy investigating the efficacy and safety of pamrevlumab versus standard of care in patients with severe COVID-19 infection. The BOREA Phase 2/3 investigator-initiated

LONDON (Reuters Breakingviews) - AstraZeneca’s approach to rival Gilead Sciences is a puzzle for shareholders, but also a warning. Chief Executive Pascal Soriot has done well for the $140 billion drugmaker’s investors. The risk is that the company’s debt load, or h

(RTTNews) - Eli Lilly and Co. (LLY) announced Monday that its Shanghai-based partner Junshi Biosciences has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment designed to fight COVID-19.

EU antitrust enforcers, boosted by recent court victories, on Monday reinforced their case against Israeli drugmaker Teva over its deal with rival Cephalon to delay selling a generic version of its sleep disorder drug modafinil.

After bottoming out in late-March, the U.S. stock market indices rebounded strongly in the past two months from the pessimism surrounding the coronavirus crisis. Since April, the Dow Jones, the Nasdaq, and the S&P 500 indices have appreciated 23.7%, 27.5%, and 23.6%, respect

As of late, it has definitely been a great time to be an investor in Amneal Pharmaceuticals, Inc. AMRX. The stock has moved higher by 39.4% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could s

As of late, it has definitely been a great time to be an investor in Range Resources Corporation RRC. The stock has moved higher by 15.2% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could sug